Healthequity Current Assets vs Receivables Analysis

HQY
 Stock
  

USD 60.09  2.75  4.80%   

Healthequity financial indicator trend analysis is much more than just examining Healthequity latest accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Healthequity is a good investment. Please check the relationship between Healthequity Current Assets and its Trade and Non Trade Receivables accounts. Please check Risk vs Return Analysis.

Current Assets vs Trade and Non Trade Receivables

Current Assets vs Receivables Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Healthequity Current Assets account and Receivables. At this time, the significance of the direction appears to have strong relationship.
The correlation between Healthequity's Current Assets and Receivables is 0.78. Overlapping area represents the amount of variation of Current Assets that can explain the historical movement of Receivables in the same time period over historical financial statements of Healthequity, assuming nothing else is changed. The correlation between historical values of Healthequity's Current Assets and Receivables is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Current Assets of Healthequity are associated (or correlated) with its Receivables. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Receivables has no effect on the direction of Current Assets i.e., Healthequity's Current Assets and Receivables go up and down completely randomly.

Correlation Coefficient

0.78
Relationship DirectionPositive 
Relationship StrengthSignificant

Current Assets

Current assets of Healthequity include cash, cash equivalents, short-term investments, accounts receivable, stock inventory and the portion of prepaid liabilities which will be paid within a year. Depending on the nature of the business, current assets can range from barrels of crude oil, to baked goods, to foreign currency. Current assets are important because they are the assets that are used to fund day-to-day operations of Healthequity. The current portion of Total Assets; reported if a company operates a classified balance sheet that segments current and non-current assets.

Trade and Non Trade Receivables

A component of Total Assets representing trade and non-trade receivables.
Most indicators from Healthequity fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Healthequity current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Please check Risk vs Return Analysis.Healthequity Selling General and Administrative Expense is fairly stable at the moment as compared to the past year. Healthequity reported Selling General and Administrative Expense of 142.98 Million in 2021. Issuance Purchase of Equity Shares is likely to rise to about 503.2 M in 2022, whereas Net Cash Flow Business Acquisitions and Disposals is likely to drop (489.9 M) in 2022.
 2019 2020 2021 2022 (projected)
Interest Expense24.77 M34.88 M36.57 M39.46 M
Gross Profit325.91 M415.33 M423.71 M457.16 M

Healthequity fundamental ratios Correlations

-0.44-0.25-0.45-0.36-0.44-0.350.310.250.36-0.41-0.440.18-0.3-0.3-0.46-0.47-0.45-0.25-0.46-0.440.050.25
-0.440.770.990.780.980.660.310.25-0.860.990.980.620.790.790.960.960.950.770.941.0-0.81-0.74
-0.250.770.750.420.760.330.14-0.14-0.790.840.770.470.990.990.620.590.621.00.530.77-0.56-0.99
-0.450.990.750.731.00.610.250.21-0.870.981.00.560.780.780.970.970.970.750.961.0-0.82-0.73
-0.360.780.420.730.670.980.570.6-0.620.770.670.780.460.460.670.760.660.420.720.78-0.67-0.37
-0.440.980.761.00.670.540.20.16-0.860.971.00.520.780.780.980.960.980.760.950.99-0.8-0.74
-0.350.660.330.610.980.540.570.61-0.510.660.530.740.360.360.540.630.520.330.590.65-0.59-0.27
0.310.310.140.250.570.20.570.88-0.10.290.20.840.110.110.220.240.220.140.250.31-0.41-0.06
0.250.25-0.140.210.60.160.610.88-0.110.210.150.69-0.13-0.130.230.310.22-0.140.310.24-0.380.21
0.36-0.86-0.79-0.87-0.62-0.86-0.51-0.1-0.11-0.91-0.86-0.45-0.82-0.82-0.77-0.85-0.76-0.79-0.76-0.860.670.8
-0.410.990.840.980.770.970.660.290.21-0.910.970.630.860.860.910.920.90.840.880.99-0.79-0.82
-0.440.980.771.00.671.00.530.20.15-0.860.970.510.790.790.980.960.970.770.950.99-0.8-0.75
0.180.620.470.560.780.520.740.840.69-0.450.630.510.470.470.480.510.480.470.490.62-0.62-0.41
-0.30.790.990.780.460.780.360.11-0.13-0.820.860.790.471.00.640.630.640.990.570.8-0.55-0.99
-0.30.790.990.780.460.780.360.11-0.13-0.820.860.790.471.00.640.630.640.990.570.8-0.55-0.99
-0.460.960.620.970.670.980.540.220.23-0.770.910.980.480.640.640.981.00.620.990.96-0.81-0.59
-0.470.960.590.970.760.960.630.240.31-0.850.920.960.510.630.630.980.970.590.990.96-0.81-0.57
-0.450.950.620.970.660.980.520.220.22-0.760.90.970.480.640.641.00.970.620.990.95-0.81-0.59
-0.250.771.00.750.420.760.330.14-0.14-0.790.840.770.470.990.990.620.590.620.530.77-0.56-0.99
-0.460.940.530.960.720.950.590.250.31-0.760.880.950.490.570.570.990.990.990.530.94-0.8-0.51
-0.441.00.771.00.780.990.650.310.24-0.860.990.990.620.80.80.960.960.950.770.94-0.81-0.74
0.05-0.81-0.56-0.82-0.67-0.8-0.59-0.41-0.380.67-0.79-0.8-0.62-0.55-0.55-0.81-0.81-0.81-0.56-0.8-0.810.52
0.25-0.74-0.99-0.73-0.37-0.74-0.27-0.060.210.8-0.82-0.75-0.41-0.99-0.99-0.59-0.57-0.59-0.99-0.51-0.740.52
Click cells to compare fundamentals

Healthequity Account Relationship Matchups

Healthequity fundamental ratios Accounts

201720182019202020212022 (projected)
Receivables21.6 M25.67 M70.86 M72.77 M87.43 M94.33 M
Accounts Payable2.42 M3.52 M3.98 M1.61 M27.54 M29.72 M
Total Assets369.16 M510.02 M2.56 B2.71 B3.11 B3.35 B
Current Assets265.4 M394.68 M297.3 M460.18 M351.34 M316.71 M
Assets Non Current103.76 M115.34 M2.27 B2.25 B2.76 B2.97 B
Cash and Equivalents199.47 M361.48 M191.73 M328.8 M225.41 M214.87 M
Cash and Equivalents USD199.47 M361.48 M191.73 M328.8 M225.41 M214.87 M
Shareholders Equity346.27 M477.08 M1.03 B1.38 B1.85 B2 B
Shareholders Equity USD346.27 M477.08 M1.03 B1.38 B1.85 B2 B
Goodwill and Intangible Assets88.29 M84.32 M2.12 B2.09 B2.62 B2.83 B
Total Liabilities22.89 M32.94 M1.53 B1.33 B1.25 B1.35 B
Current Liabilities20.49 M29.05 M151.94 M204.7 M153.19 M165.28 M
Liabilities Non Current2.4 M3.88 M1.38 B1.13 B1.1 B1.19 B
Trade and Non Trade Payables2.42 M3.52 M3.98 M1.61 M27.54 M29.72 M
Property Plant and Equipment Net7.84 M8.22 M116.66 M118.61 M86.98 M93.85 M
Trade and Non Trade Receivables21.6 M25.67 M70.86 M72.77 M87.43 M94.33 M
Accumulated Retained Earnings Deficit85.3 M171.85 M211.51 M220.35 M176.06 M141.49 M
Tax Assets1.61 M5.46 M1.68 M18 K16.2 K16.63 K

Be your own money manager

Our tools can tell you how much better you can do entering a position in Healthequity without increasing your portfolio risk or giving up expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate.risk-adjusted returns of your individual positions relative to your overall portfolio.

Did you try this?

Run Shere Portfolio Now

   

Shere Portfolio

Track or share privately all of your investments from the convenience of any device
All  Next Launch Module

Becoming a Better Investor with Macroaxis

Macroaxis puts the power of mathematics on your side. We analyze your portfolios and positions such as Healthequity using complex mathematical models and algorithms, but make them easy to understand. There is no real person involved in your portfolio analysis. We perform a number of calculations to compute absolute and relative portfolio volatility, correlation between your assets, value at risk, expected return as well as over 100 different fundamental and technical indicators.

Build Optimal Portfolios

Align your risk with return expectations

Fix your portfolio
By capturing your risk tolerance and investment horizon Macroaxis technology of instant portfolio optimization will compute exactly how much risk is acceptable for your desired return expectations
Please check Risk vs Return Analysis. Note that the Healthequity information on this page should be used as a complementary analysis to other Healthequity's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Price Exposure Probability module to analyze equity upside and downside potential for a given time horizon across multiple markets.

Complementary Tools for Healthequity Stock analysis

When running Healthequity price analysis, check to measure Healthequity's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Healthequity is operating at the current time. Most of Healthequity's value examination focuses on studying past and present price action to predict the probability of Healthequity's future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Healthequity's price. Additionally, you may evaluate how the addition of Healthequity to your portfolios can decrease your overall portfolio volatility.
Equity Analysis
Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities
Go
Correlation Analysis
Reduce portfolio risk simply by holding instruments which are not perfectly correlated
Go
Pattern Recognition
Use different Pattern Recognition models to time the market across multiple global exchanges
Go
Portfolio Diagnostics
Use generated alerts and portfolio events aggregator to diagnose current holdings
Go
Insider Screener
Find insiders across different sectors to evaluate their impact on performance
Go
Equity Valuation
Check real value of public entities based on technical and fundamental data
Go
Focused Opportunities
Build portfolios using our predefined set of ideas and optimize them against your investing preferences
Go
Bond Directory
Find actively traded corporate debentures issued by US companies
Go
My Watchlist Analysis
Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like
Go
Portfolio Manager
State of the art Portfolio Manager to monitor and improve performance of your invested capital
Go
Price Ceiling Movement
Calculate and plot Price Ceiling Movement for different equity instruments
Go
Is Healthequity's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Healthequity. If investors know Healthequity will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Healthequity listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth YOY
-0.96
Market Capitalization
5.1 B
Quarterly Revenue Growth YOY
0.12
Return On Assets
0.0059
Return On Equity
-0.0299
The market value of Healthequity is measured differently than its book value, which is the value of Healthequity that is recorded on the company's balance sheet. Investors also form their own opinion of Healthequity's value that differs from its market value or its book value, called intrinsic value, which is Healthequity's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Healthequity's market value can be influenced by many factors that don't directly affect Healthequity's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Healthequity's value and its price as these two are different measures arrived at by different means. Investors typically determine Healthequity value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Healthequity's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.